128 related articles for article (PubMed ID: 38325551)
1. Computational Pathology for Prediction of Isocitrate Dehydrogenase Gene Mutation from Whole Slide Images in Adult Patients with Diffuse Glioma.
Zhao Y; Wang W; Ji Y; Guo Y; Duan J; Liu X; Yan D; Liang D; Li W; Zhang Z; Li ZC
Am J Pathol; 2024 May; 194(5):747-758. PubMed ID: 38325551
[TBL] [Abstract][Full Text] [Related]
2. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
[TBL] [Abstract][Full Text] [Related]
3. Generative AI in glioma: Ensuring diversity in training image phenotypes to improve diagnostic performance for IDH mutation prediction.
Moon HH; Jeong J; Park JE; Kim N; Choi C; Kim YH; Song SW; Hong CK; Kim JH; Kim HS
Neuro Oncol; 2024 Jun; 26(6):1124-1135. PubMed ID: 38253989
[TBL] [Abstract][Full Text] [Related]
4. Deep wavelet scattering orthogonal fusion network for glioma IDH mutation status prediction.
Chen Q; Wang L; Xing Z; Wang L; Hu X; Wang R; Zhu YM
Comput Biol Med; 2023 Nov; 166():107493. PubMed ID: 37774558
[TBL] [Abstract][Full Text] [Related]
5. Insight into deep learning for glioma IDH medical image analysis: A systematic review.
Lv Q; Liu Y; Sun Y; Wu M
Medicine (Baltimore); 2024 Feb; 103(7):e37150. PubMed ID: 38363910
[TBL] [Abstract][Full Text] [Related]
6. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.
Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN
Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515
[TBL] [Abstract][Full Text] [Related]
7. Whole brain morphologic features improve the predictive accuracy of IDH status and VEGF expression levels in gliomas.
Zhang S; Chen D; Sun H; Kemp GJ; Chen Y; Tan Q; Yang Y; Gong Q; Yue Q
Cereb Cortex; 2024 Apr; 34(4):. PubMed ID: 38642107
[TBL] [Abstract][Full Text] [Related]
8. Natural language processing to predict isocitrate dehydrogenase genotype in diffuse glioma using MR radiology reports.
Kim M; Ong KT; Choi S; Yeo J; Kim S; Han K; Park JE; Kim HS; Choi YS; Ahn SS; Kim J; Lee SK; Sohn B
Eur Radiol; 2023 Nov; 33(11):8017-8025. PubMed ID: 37566271
[TBL] [Abstract][Full Text] [Related]
9. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK
Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862
[TBL] [Abstract][Full Text] [Related]
10. Swin Transformer Improves the IDH Mutation Status Prediction of Gliomas Free of MRI-Based Tumor Segmentation.
Wu J; Xu Q; Shen Y; Chen W; Xu K; Qi XR
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956236
[No Abstract] [Full Text] [Related]
11. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
[TBL] [Abstract][Full Text] [Related]
12. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.
Alfaro CM; Pirro V; Keating MF; Hattab EM; Cooks RG; Cohen-Gadol AA
J Neurosurg; 2019 Jan; 132(1):180-187. PubMed ID: 30611146
[TBL] [Abstract][Full Text] [Related]
14. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
15. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
Choi KS; Choi SH; Jeong B
Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
[TBL] [Abstract][Full Text] [Related]
16. Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach.
Karabacak M; Ozkara BB; Mordag S; Bisdas S
Quant Imaging Med Surg; 2022 Aug; 12(8):4033-4046. PubMed ID: 35919062
[TBL] [Abstract][Full Text] [Related]
17. Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.
Liu S; Shah Z; Sav A; Russo C; Berkovsky S; Qian Y; Coiera E; Di Ieva A
Sci Rep; 2020 May; 10(1):7733. PubMed ID: 32382048
[TBL] [Abstract][Full Text] [Related]
18. Deep-learning and conventional radiomics to predict
Zhang H; Fan X; Zhang J; Wei Z; Feng W; Hu Y; Ni J; Yao F; Zhou G; Wan C; Zhang X; Wang J; Liu Y; You Y; Yu Y
Front Oncol; 2023; 13():1143688. PubMed ID: 37711207
[TBL] [Abstract][Full Text] [Related]
19. Predicting isocitrate dehydrogenase status among adult patients with diffuse glioma using patient characteristics, radiomic features, and magnetic resonance imaging: Multi-modal analysis by variable vision transformer.
Usuzaki T; Inamori R; Shizukuishi T; Morishita Y; Takagi H; Ishikuro M; Obara T; Takase K
Magn Reson Imaging; 2024 May; 111():266-276. PubMed ID: 38815636
[TBL] [Abstract][Full Text] [Related]
20. Static
Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]